3.23.3 html 240 308 1 false 68 0 false 8 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100030 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100050 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss Statements 4 false false R5.htm 100060 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 100070 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100080 - Disclosure - Nature of the Business Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureNatureOfBusiness Nature of the Business Notes 7 false false R8.htm 100090 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100100 - Disclosure - Marketable Securities Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureMarketableSecurities Marketable Securities Notes 9 false false R10.htm 100110 - Disclosure - Fair Value Measurements Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 100120 - Disclosure - Leases Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureLeases Leases Notes 11 false false R12.htm 100130 - Disclosure - Accrued Expenses Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureAccruedExpenses Accrued Expenses Notes 12 false false R13.htm 100140 - Disclosure - Debt Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureDebt Debt Notes 13 false false R14.htm 100150 - Disclosure - Stockholders' Equity Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureStockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 100160 - Disclosure - Income Taxes Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxes Income Taxes Notes 15 false false R16.htm 100170 - Disclosure - Net Loss per Share Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureNetLossPerShare Net Loss per Share Notes 16 false false R17.htm 100180 - Disclosure - Collaborative and Licensing Agreements Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureCollaborativeAndLicensingAgreements Collaborative and Licensing Agreements Notes 17 false false R18.htm 100190 - Disclosure - Commitments and Contingencies Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 100210 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 19 false false R20.htm 100220 - Disclosure - Marketable Securities (Tables) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureMarketableSecuritiesTables Marketable Securities (Tables) Tables http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureMarketableSecurities 20 false false R21.htm 100230 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureFairValueMeasurements 21 false false R22.htm 100240 - Disclosure - Leases (Tables) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureLeasesTables Leases (Tables) Tables http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureLeases 22 false false R23.htm 100250 - Disclosure - Accrued Expenses (Tables) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureAccruedExpenses 23 false false R24.htm 100260 - Disclosure - Debt (Tables) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureDebtTables Debt (Tables) Tables http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureDebt 24 false false R25.htm 100270 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureStockholdersEquity 25 false false R26.htm 100280 - Disclosure - Net Loss per Share (Tables) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureNetLossPerShareTables Net Loss per Share (Tables) Tables http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureNetLossPerShare 26 false false R27.htm 100290 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 27 false false R28.htm 100300 - Disclosure - Marketable Securities - Schedule of Fair Value And Amortized Cost Of Available-for-sale Marketable Securities (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureMarketableSecuritiesScheduleOfFairValueAndAmortizedCostOfAvailableForSaleMarketableSecuritiesDetail Marketable Securities - Schedule of Fair Value And Amortized Cost Of Available-for-sale Marketable Securities (Detail) Details 28 false false R29.htm 100310 - Disclosure - Marketable Securities - Summary Of Contractual Maturities Of Available-for-sale Marketable Securities (Details) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/DisclosureMarketableSecuritiesSummaryOfContractualMaturitiesOfAvailableforsaleMarketableSecuritiesDetails Marketable Securities - Summary Of Contractual Maturities Of Available-for-sale Marketable Securities (Details) Details 29 false false R30.htm 100320 - Disclosure - Marketable Securities - Additional Information (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetail Marketable Securities - Additional Information (Detail) Details 30 false false R31.htm 100330 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndFinancialLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail Fair Value Measurements - Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on Recurring Basis (Detail) Details 31 false false R32.htm 100340 - Disclosure - Leases - Additional Information (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail Leases - Additional Information (Detail) Details 32 false false R33.htm 100350 - Disclosure - Leases - Schedule of Lease-related Assets and Liabilities (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaserelatedAssetsAndLiabilitiesDetail Leases - Schedule of Lease-related Assets and Liabilities (Detail) Details 33 false false R34.htm 100360 - Disclosure - Leases - Schedule of Information Related to Lease Expenses (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfInformationRelatedToLeaseExpensesDetail Leases - Schedule of Information Related to Lease Expenses (Detail) Details 34 false false R35.htm 100370 - Disclosure - Leases - Future Minimum Lease Payments (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureLeasesFutureMinimumLeasePaymentsDetail Leases - Future Minimum Lease Payments (Detail) Details 35 false false R36.htm 100380 - Disclosure - Leases - Schedule of Information Related to the Lease Terms and Discount Rates of Leases (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfInformationRelatedToTheLeaseTermsAndDiscountRatesOfLeasesDetail Leases - Schedule of Information Related to the Lease Terms and Discount Rates of Leases (Detail) Details 36 false false R37.htm 100390 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetail Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Detail) Details 37 false false R38.htm 100400 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetail Accrued Expenses - Schedule of Accrued Expenses (Detail) Details 38 false false R39.htm 100410 - Disclosure - Debt - Additional Information (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail Debt - Additional Information (Detail) Details 39 false false R40.htm 100420 - Disclosure - Debt - Schedule of Outstanding Borrowings under SVB Term Loan (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureDebtScheduleOfOutstandingBorrowingsUnderSVBTermLoanDetail Debt - Schedule of Outstanding Borrowings under SVB Term Loan (Detail) Details 40 false false R41.htm 100440 - Disclosure - Debt - Schedule of Components of Interest Expense of Term Loan (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureDebtScheduleOfComponentsOfInterestExpenseOfTermLoanDetail Debt - Schedule of Components of Interest Expense of Term Loan (Detail) Details 41 false false R42.htm 100450 - Disclosure - Stockholders' Equity - Shares Reserved For Future Issuances (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureStockholdersEquitySharesReservedForFutureIssuancesDetail Stockholders' Equity - Shares Reserved For Future Issuances (Detail) Details 42 false false R43.htm 100460 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 43 false false R44.htm 100470 - Disclosure - Stockholders' Equity - Warrant Activity Including Activity Related To Pre-funded Warrants (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureStockholdersEquityWarrantActivityIncludingActivityRelatedToPreFundedWarrantsDetail Stockholders' Equity - Warrant Activity Including Activity Related To Pre-funded Warrants (Detail) Details 44 false false R45.htm 100480 - Disclosure - Stockholders' Equity (Stock-Based Awards) - Additional Information (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureStockholdersEquityStockBasedAwardsAdditionalInformationDetail Stockholders' Equity (Stock-Based Awards) - Additional Information (Detail) Details http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureStockholdersEquityTables 45 false false R46.htm 100490 - Disclosure - Stockholders' Equity - Stock Options, Activity (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureStockholdersEquityStockOptionsActivityDetail Stockholders' Equity - Stock Options, Activity (Detail) Details 46 false false R47.htm 100500 - Disclosure - Stockholders' Equity - Stock-based Compensation Expenses (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureStockholdersEquityStockBasedCompensationExpensesDetail Stockholders' Equity - Stock-based Compensation Expenses (Detail) Details 47 false false R48.htm 100510 - Disclosure - Net Loss per Share - Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetail Net Loss per Share - Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Detail) Details 48 false false R49.htm 100520 - Disclosure - Net Loss per Share - Additional Information (Details) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureNetLossPerShareAdditionalInformationDetails Net Loss per Share - Additional Information (Details) Details 49 false false R50.htm 100530 - Disclosure - Net Loss per Share - Calculation of Diluted Net Loss Per Share Attributable to Common Stockholders (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureNetLossPerShareCalculationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail Net Loss per Share - Calculation of Diluted Net Loss Per Share Attributable to Common Stockholders (Detail) Details 50 false false R51.htm 100540 - Disclosure - Collaborative and Licensing Agreements - Additional Information (Detail) Sheet http://www.trevitherapeutics.com/20230930/taxonomy/role/Role_DisclosureCollaborativeAndLicensingAgreementsAdditionalInformationDetail Collaborative and Licensing Agreements - Additional Information (Detail) Details 51 false false All Reports Book All Reports trvi-20230930.htm trvi-20230930.xsd trvi-20230930_cal.xml trvi-20230930_def.xml trvi-20230930_lab.xml trvi-20230930_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true